Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Dynavax Technologies Corp has a consensus price target of $26.5 based on the ratings of 4 analysts. The high is $33 issued by Citizens Capital Markets on February 21, 2025. The low is $10 issued by Goldman Sachs on April 17, 2025. The 3 most-recent analyst ratings were released by JMP Securities on August 22, 2025, August 8, 2025, and May 7, 2025, respectively. With an average price target of $31.67 between JMP Securities, there's an implied 191.86% upside for Dynavax Technologies Corp from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Aug 22, 2025 | 194.93% | 3232 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Aug 8, 2025 | 194.93% | 3132 | Previous Market Outperform Current Market Outperform | Get Alert | |
| May 7, 2025 | 185.71% | 3133 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Apr 17, 2025 | -7.83% | 1012 | Previous Sell Current Sell | Get Alert | |
| Feb 21, 2025 | 204.15% | 2933 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Feb 21, 2025 | 185.71% | 3131 | Previous Buy Current Buy | Get Alert | |
| Feb 11, 2025 | 10.6% | 1215 | Previous Neutral Current Sell | Get Alert | |
| Jan 14, 2025 | 185.71% | 2931 | Previous Buy Current Buy | Get Alert | |
| Nov 8, 2024 | 167.28% | 2929 | Previous Buy Current Buy | Get Alert | |
| Oct 15, 2024 | 167.28% | 2929 | Previous Buy Current Buy | Get Alert | |
| Aug 8, 2024 | 38.25% | 1520 | Previous Neutral Current Neutral | Get Alert | |
| Aug 7, 2024 | 167.28% | 2929 | Previous Buy Current Buy | Get Alert | |
| Jun 28, 2024 | 167.28% | 2929 | Previous Buy Current Buy | Get Alert | |
| May 14, 2024 | 167.28% | 2929 | Previous Buy Current Buy | Get Alert | |
| May 9, 2024 | 167.28% | 2929 | Previous Buy Current Buy | Get Alert | |
| Feb 1, 2024 | 84.33% | 20 | Previous Initiates Current Neutral | Get Alert | |
| Nov 3, 2023 | 148.85% | 2527 | Previous Market Outperform Current Market Outperform | Get Alert | |
| Nov 3, 2023 | 158.06% | 2728 | Previous Buy Current Buy | Get Alert | |
| Aug 4, 2023 | 148.85% | 27 | Previous Buy Current Buy | Get Alert | |
| Aug 4, 2023 | 130.41% | 2425 | Previous Outperform Current Outperform | Get Alert | |
| May 3, 2023 | 121.2% | 2425 | Previous Current Outperform | Get Alert | |
| May 3, 2023 | 148.85% | 27 | Previous Current Buy | Get Alert | |
| Feb 24, 2023 | 130.41% | 2225 | Previous Current Market Outperform | Get Alert | |
| Feb 24, 2023 | 148.85% | 2728 | Previous Current Buy | Get Alert |
The latest price target for Dynavax Technologies (NASDAQ:DVAX) was reported by JMP Securities on August 22, 2025. The analyst firm set a price target for $32.00 expecting DVAX to rise to within 12 months (a possible 194.93% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Dynavax Technologies (NASDAQ:DVAX) was provided by JMP Securities, and Dynavax Technologies reiterated their market outperform rating.
There is no last upgrade for Dynavax Technologies
The last downgrade for Dynavax Technologies Corp happened on February 11, 2025 when Goldman Sachs changed their price target from $15 to $12 for Dynavax Technologies Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on August 22, 2025 so you should expect the next rating to be made available sometime around August 22, 2026.
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a reiterated with a price target of $32.00 to $32.00. The current price Dynavax Technologies (DVAX) is trading at is $10.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.